Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2970]

$FDA approves enasidenib for relapsed or refractory acute myeloid leukaemia$

FDA approves enasidenib for relapsed or refractory acute myeloid leukaemia

Durvalumab granted breakthrough designation by FDA for locally advanced unresectable NSCLC

Durvalumab granted breakthrough designation by FDA for locally advanced unresectable NSCLC

Error clusters made by DNA repair revealed as important cause of cancer

Error clusters made by DNA repair revealed as important cause of cancer

Researchers release first draft of a genome-wide cancer 'dependency map'

Researchers release first draft of a genome-wide cancer 'dependency map'

Understanding cell segregation mechanisms which help prevent cancer spread

Understanding cell segregation mechanisms which help prevent cancer spread

Inflammation signalling may provide insight into early cancer detection

Inflammation signalling may provide insight into early cancer detection

Nivolumab plus ipilimumab shows better tolerance, effectiveness in metastatic kidney cancer

Nivolumab plus ipilimumab shows better tolerance, effectiveness in metastatic kidney cancer

Stem cell therapy attacks cancer by targeting unique tissue stiffness

Stem cell therapy attacks cancer by targeting unique tissue stiffness

Combining intraoperative imaging with PET scans helps surgeons identify malignant nodules

Combining intraoperative imaging with PET scans helps surgeons identify malignant nodules

Clinical data confirms efficacy of pre-surgery chemo in triple-negative breast cancer

Clinical data confirms efficacy of pre-surgery chemo in triple-negative breast cancer

More from ecancer